Fundraising FoxAboleris Pharma
5 known investors
Find your way into Aboleris Pharma
Sign up to see every warm intro you have to Aboleris Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aboleris Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AbolerIS Pharma develops therapeutic approaches that regulate the immune system by inducing immune tolerance while preserving useful immune responses, targeting inflammatory, autoimmune, and degenerative diseases. It is a biotech company working on drug candidates based on regulatory T cell research.
Founders & leadership
Investors · 5
How we know: the company's own site · Not right? Tell us
How we know: Newton Biocapital's portfolio page · the company's own site · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the company's own site · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Aboleris Pharma do?
- AbolerIS Pharma develops therapeutic approaches that regulate the immune system by inducing immune tolerance while preserving useful immune responses, targeting inflammatory, autoimmune, and degenerative diseases. It is a biotech company working on drug candidates based on regulatory T cell research.
- Who founded Aboleris Pharma?
- Aboleris Pharma was founded by Ignacio Anegon, Carole Guillonneau, François-Xavier Hubert.
- Who are Aboleris Pharma's investors?
- Aboleris Pharma's investors include Criteria Bio Ventures, Newton Biocapital, Sound Bioventures, Sambrinvest, Wallonie Entreprendre.